Dasatinib enhances anti-tumor efficacy of chimeric antigen receptor T cells by inhibiting cell differentiation and exhaustion
Ontology highlight
ABSTRACT: Dasatinib enhances anti-tumor efficacy of chimeric antigen receptor T cells by inhibiting cell differentiation and exhaustion
PROVIDER: PRJNA637236 | ENA |
REPOSITORIES: ENA
ACCESS DATA